BACKGROUND: Accurate preoperative lymphoscintigraphy is vital to performing sentinel lymph node biopsy (SLNB) for cutaneous malignancies. Potential advantages of single-photon emission computed tomography with integrated computed tomography (SPECT/CT) include the ability to readily identify aberrant drainage patterns as well as provide the surgeon with three-dimensional anatomic landmarks not seen on conventional planar lymphoscintigraphy (PLS). METHODS: Patients with cutaneous malignancies who underwent SLNB with preoperative imaging using both SPECT/CT and PLS from 2011 to 2014 were identified. RESULTS: Both SPECT/CT and PLS were obtained in 351 patients (median age, 69 years; range, 5-94 years) with cutaneous malignancies (melanoma = 300, Merkel cell carcinoma = 33, squamous cell carcinoma = 8, other = 10) after intradermal injection of 99mtechnetium sulfur colloid (median dose 300 µCi). A mean of 4.3 hot spots were identified on SPECT/CT compared to 3.0 on PLS (p < 0.001). One hundred fifty-three patients (43.6 %) had identical findings between SPECT/CT and PLS, while 172 (49 %) had additional hot spots identified on SPECT/CT compared to only 24 (6.8 %) additional on PLS. SPECT/CT demonstrated additional nodal basins in 103 patients (29.4 %), compared to only 11 patients (3.1 %) with additional basins on PLS. CONCLUSIONS: SPECT/CT is a useful adjunct that can help with sentinel node localization in challenging cases. It identified additional hot spots not seen on PLS in almost 50 % of patients. Because PLS identified hot spots not seen on SPECT/CT in 6.8 % of patients, we recommend using both modalities jointly. Long-term follow-up will be required to validate the clinical significance of the additional hot spots identified by SPECT/CT.
BACKGROUND: Accurate preoperative lymphoscintigraphy is vital to performing sentinel lymph node biopsy (SLNB) for cutaneous malignancies. Potential advantages of single-photon emission computed tomography with integrated computed tomography (SPECT/CT) include the ability to readily identify aberrant drainage patterns as well as provide the surgeon with three-dimensional anatomic landmarks not seen on conventional planar lymphoscintigraphy (PLS). METHODS:Patients with cutaneous malignancies who underwent SLNB with preoperative imaging using both SPECT/CT and PLS from 2011 to 2014 were identified. RESULTS: Both SPECT/CT and PLS were obtained in 351 patients (median age, 69 years; range, 5-94 years) with cutaneous malignancies (melanoma = 300, Merkel cell carcinoma = 33, squamous cell carcinoma = 8, other = 10) after intradermal injection of 99mtechnetium sulfur colloid (median dose 300 µCi). A mean of 4.3 hot spots were identified on SPECT/CT compared to 3.0 on PLS (p < 0.001). One hundred fifty-three patients (43.6 %) had identical findings between SPECT/CT and PLS, while 172 (49 %) had additional hot spots identified on SPECT/CT compared to only 24 (6.8 %) additional on PLS. SPECT/CT demonstrated additional nodal basins in 103 patients (29.4 %), compared to only 11 patients (3.1 %) with additional basins on PLS. CONCLUSIONS: SPECT/CT is a useful adjunct that can help with sentinel node localization in challenging cases. It identified additional hot spots not seen on PLS in almost 50 % of patients. Because PLS identified hot spots not seen on SPECT/CT in 6.8 % of patients, we recommend using both modalities jointly. Long-term follow-up will be required to validate the clinical significance of the additional hot spots identified by SPECT/CT.
Authors: L Jansen; O E Nieweg; A E Kapteijn; R A Valdés Olmos; S H Muller; C A Hoefnagel; B B Kroon Journal: Ann Surg Oncol Date: 2000-09 Impact factor: 5.344
Authors: J F Thompson; R F Uren; H M Shaw; W H McCarthy; M J Quinn; C J O'Brien; R B Howman-Giles Journal: J Am Coll Surg Date: 1999-08 Impact factor: 6.113
Authors: J Klode; T Poeppel; C Boy; S Mueller; D Schadendorf; A Körber; I Stoffels; J Dissemond Journal: J Eur Acad Dermatol Venereol Date: 2010-12-29 Impact factor: 6.166
Authors: B A Kapteijn; O E Nieweg; I Liem; W J Mooi; A J Balm; S H Muller; J L Peterse; R A Valdés Olmos; C A Hoefnagel; B B Kroon Journal: Ann Surg Oncol Date: 1997-03 Impact factor: 5.344
Authors: Markwin G Statius Muller; Feitse A Hennipman; Paul A M van Leeuwen; Rik Pijpers; Ronald J Vuylsteke; Sybren Meijer Journal: Eur J Nucl Med Mol Imaging Date: 2002-02 Impact factor: 9.236
Authors: Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harold J Hoekstra; Constantine P Karakousis; Christopher A Puleo; Brendon J Coventry; Mohammed Kashani-Sabet; B Mark Smithers; Eberhard Paul; William G Kraybill; J Gregory McKinnon; He-Jing Wang; Robert Elashoff; Mark B Faries Journal: N Engl J Med Date: 2014-02-13 Impact factor: 91.245
Authors: Dirk Schadendorf; David E Fisher; Claus Garbe; Jeffrey E Gershenwald; Jean-Jacques Grob; Allan Halpern; Meenhard Herlyn; Michael A Marchetti; Grant McArthur; Antoni Ribas; Alexander Roesch; Axel Hauschild Journal: Nat Rev Dis Primers Date: 2015-04-23 Impact factor: 52.329
Authors: Brian R Gastman; Jonathan S Zager; Jane L Messina; Robert W Cook; Kyle R Covington; Brooke Middlebrook; Pedram Gerami; Jeffrey D Wayne; Sancy Leachman; John T Vetto Journal: Head Neck Date: 2019-01-29 Impact factor: 3.147
Authors: Seth Noorbakhsh; Marianna Papageorge; Renee M Maina; Raymond Baumann; Craig Moores; Sarah A Weiss; Darko Pucar; Stephan Ariyan; Kelly Olino; James Clune Journal: Plast Reconstr Surg Glob Open Date: 2021-12-20
Authors: John E Hanks; Kevin J Kovatch; S Ahmed Ali; Emily Roberts; Alison B Durham; Joshua D Smith; Carol R Bradford; Kelly M Malloy; Philip S Boonstra; Christopher D Lao; Scott A McLean Journal: Otolaryngol Head Neck Surg Date: 2020-02-11 Impact factor: 3.497